Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > A Patent Fight Over The World’s Top-Selling Drug
Health and Wellness

A Patent Fight Over The World’s Top-Selling Drug

Last updated: April 30, 2025 11:20 am
Share
A Patent Fight Over The World’s Top-Selling Drug
SHARE

Merck’s Keytruda, the top-selling drug in the world, is facing a patent fight over its new injectable version. The drug, known for its effectiveness in treating lung cancer, melanoma, and other cancers, has generated nearly $30 billion in sales last year. Merck is planning to launch an easier-to-administer injectable version of Keytruda pending FDA approval, with a target launch date of October 1. However, San Diego-based Halozyme has filed a lawsuit against Merck in U.S. District Court, alleging patent infringement over the injectable formulation. Halozyme, known for its partnerships in creating injectable versions of medicines, claims that Merck used its hyaluronidase technology without a licensing deal. The lawsuit comes at a critical time for Keytruda, as the drug is facing patent expirations in the near future, potentially opening the door for biosimilar competition. Merck has announced plans to invest $1 billion in a new factory in Delaware to produce biologic drugs, including the new injectable version of Keytruda.

The annual meeting of the American Association of Cancer Research brought together over 21,000 attendees to showcase groundbreaking research in the fight against cancer. One of the key highlights from the event was the use of artificial intelligence in cancer diagnostics, with AI models showing promising results in predicting cancer risks and classifying different types of cancers from images alone. Boehringer Ingelheim presented data on its drug zongertinib, targeting HER2 mutations in non-small cell lung cancer, showing positive outcomes with fewer side effects. Additionally, innovative immunotherapies and diagnostic tools were discussed, including a study on the effectiveness of the HPV vaccine in preventing cervical cancer with just one dose.

See also  Q&A: How the U.S.–China rivalry is holding back the world’s climate progress

In the biotech and pharma sector, Sudip Parikh, CEO of the American Association for the Advancement of Science, testified to the Senate Appropriations Committee about the impact of budget cuts on biomedical research. Parikh criticized the Trump administration’s decisions, stating that they could lead to fewer treatments for cancer and other diseases, potentially jeopardizing America’s leadership in biomedical research. A study by economists at American University warned that significant reductions in research funding could have long-term negative effects on government revenues. The FDA also approved Abeona Therapeutics’ gene therapy Zevaskyn for a rare genetic condition causing fragile skin.

Verily, Alphabet’s health and AI company, received a substantial grant from the Michael J. Fox Foundation to create a large molecular dataset of Parkinson’s patients, aiming to accelerate new treatments for the disease. In the field of medtech, diagnostics company Predicta Biosciences launched its GenoPredicta test for multiple myeloma, using whole genome sequencing to guide treatment decisions. The test offers a less invasive alternative to traditional diagnostic methods, providing more accurate and personalized results.

A recent study linked exposure to phthalates, chemicals found in plastics, to an increased risk of heart disease and hundreds of thousands of related deaths annually. Novo Nordisk announced plans to sell low-cost versions of its weight-loss drug Wegovy through telehealth companies, following the end of a FDA-permitted shortage. Overture Life, a company specializing in IVF automation, secured $21 million in funding to further develop its technology.

On the public health front, a study highlighted the damaging effects of certain gut bacteria on colon cancer rates in younger individuals. Chinese biotech company Akeso received approval in China for a drug challenging Merck’s Keytruda, with Summit Therapeutics partnering for its U.S. development. The impact of Trump’s science funding cuts was underscored by the potential euthanization of research animals due to lack of funding. Health system operating margins dropped below 1% in March, indicating financial challenges in the industry.

See also  How Kissing May Have Evolved In Humans. Here’s Evidence From Great Apes

In conclusion, the healthcare and biotech industries continue to see advancements and challenges, with innovative research and treatments paving the way for improved patient outcomes. Collaboration between companies, research institutions, and regulatory bodies is crucial in driving progress and addressing complex health issues.

TAGGED:DrugfightpatentTopSellingworlds
Share This Article
Twitter Email Copy Link Print
Previous Article Just being on park highlight for Wheeley Just being on park highlight for Wheeley
Next Article Axolotls raised in captivity can survive in the wild Axolotls raised in captivity can survive in the wild
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

“Not good enough anymore” – NBA analyst gives Kawhi Leonard and James Harden harsh reality check

The Los Angeles Clippers faced a tough challenge in the first round of the playoffs…

May 4, 2025

Tim McGraw With Faith Hill in Copenhagen After Back Surgery

Tim McGraw and his wife Faith Hill were recently spotted enjoying the European sunshine as…

July 2, 2025

Mamdanis terror-linked imam pal urged jihad on NYC with army of 10,000 men

The Brooklyn imam with ties to terror who recently took part in a photo opportunity…

October 18, 2025

Technology retailer closing over 1,000 stores, no bankruptcy

A major challenge for retailers arises when a competitor discovers a more convenient method to…

October 9, 2025

Federal judge declares Texas law granting illegal migrants in-state college tuition unconstitutional after state joins Trump in lawsuit

Federal Judge Blocks Texas Law Allowing In-State Tuition for Illegal Immigrants In a significant decision,…

June 4, 2025

You Might Also Like

Digital Twins Coming To Robotic Surgery
Health and Wellness

Digital Twins Coming To Robotic Surgery

October 31, 2025
Medicare, midterm elections, Vinay Prasad: Morning Rounds
Health and Wellness

Medicare, midterm elections, Vinay Prasad: Morning Rounds

October 31, 2025
Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests
Health and Wellness

Remission achievable for 1 in 3 Indian diabetics through intensive app-based lifestyle program, study suggests

October 31, 2025
Once Again A Blood Pressure Medication Recall For Cancer Concerns
Health and Wellness

Once Again A Blood Pressure Medication Recall For Cancer Concerns

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?